SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 Patient-Reported Outcomes From the TROPiCS-02 Trial: The Effect of Sacituzumab Govitecan vs. Chemotherapy in HR+/HER2- mBC
By
SABCS 2022 Conference Coverage
FEATURING
Frederik Marmé
By
SABCS 2022 Conference Coverage
FEATURING
Frederik Marmé
54 views
December 13, 2022
Login to view comments.
Click here to Login
Videos